Market Tracker

04/24 3:34pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

11.95
Data as of 3:18pm ET
 -0.1496 / -1.24%
Today’s Change
3.90
Today|||52-Week Range
19.11
+47.90%
Year-to-Date

Today’s Trading

Previous close12.10
Today’s open12.37
Day’s range11.71 - 12.41
Volume146,974
Average volume (3 months)568,769
Market cap$268.0M
Dividend yield--
Data as of 3:18pm ET, 04/24/2014

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)-79.63%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book368.18

Competitors

 Today’s
change
Today’s
% change
TTHITransition Therapeut...-0.22-4.04%
VCYTVeracyte Inc-0.27-2.01%
GERNGeron Corp+0.02+1.25%
OXFDOxford Immunotec Glo...-0.21-1.18%
Data as of 3:32pm ET, 04/24/2014

Financials

Next reporting dateMay 16, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$9.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts